Medvantx Dispenses Qlosi™: A Novel Corrective Eyedrop for Presbyopia
We are excited to announce Qlosi Home Delivery Through Medvantx Pharmacy, a novel corrective eyedrop for Presbyopia by Orasis Pharmaceuticals. Available to prescribe in the U.S. starting April 7, 2025, Qlosi™ (pilocarpine hydrochloride ophthalmic solution) 0.4% is designed to maximize efficacy while minimizing side effects. Its proprietary EyeQ Formulation™ offers patients flexible dosing options—one or two drops a day—for up to eight hours of clear near vision. Explore full article here.
At Medvantx, our commitment to quality care ensures that patients receive the best in eye care. We are proud to support patients with Presbyopia through our innovative Qlosi Home Delivery Through Medvantx Pharmacy, with convenient shipping right to their homes through our Cash Pay and Telehealth services.
Stay tuned for more updates and information Qlosi dispensing and how Medvantx continues to prioritize eye care health and well-being.
—
Interested in learning more? See related articles below.
Eyewire Article: Orasis Launches Presbyopia Eyedrop Qlosi in the US
Ophthalmology Times Article: Orasis Pharmaceuticals’ prescription pilocarpine hydrochloride ophthalmic solution 0.4% (Qlosi) for presbyopia available in the US
